APA (7th ed.) Citation

Braik, D., Ma'koseh, M., Amarin, R., Farra, A. A., Manasrah, M., Al-Rwashdeh, M., . . . Abdel-Razeq, H. (2021). ABCL-305: The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma. Clinical lymphoma, myeloma & leukemia, 21, S389. https://doi.org/10.1016/S2152-2650(21)01884-X

Chicago Style (17th ed.) Citation

Braik, Dina, Mohammad Ma'koseh, Rula Amarin, Alaa' Abu Farra, Mohammad Manasrah, Mohammad Al-Rwashdeh, Rayan Bater, and Hikmat Abdel-Razeq. "ABCL-305: The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma." Clinical Lymphoma, Myeloma & Leukemia 21 (2021): S389. https://doi.org/10.1016/S2152-2650(21)01884-X.

MLA (9th ed.) Citation

Braik, Dina, et al. "ABCL-305: The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma." Clinical Lymphoma, Myeloma & Leukemia, vol. 21, 2021, p. S389, https://doi.org/10.1016/S2152-2650(21)01884-X.